Cadaveric allograft as adjunct therapy for nonhealing ulcers

Area of Science:

• Wound healing and regenerative medicine
• Surgical and reconstructive procedures
• Biomaterials in medicine

Background:

• Lower extremity wounds pose significant treatment challenges, increasing complication risks.
• Effective wound management is crucial to prevent infection, desiccation, and tissue damage.
• Cadaveric skin allografts offer a potential solution for complex wound cases.

Purpose of the Study:

• To evaluate the effectiveness of cadaveric skin allografts in wound management.
• To describe the outcomes of using cadaveric skin allografts in a retrospective patient series.
• To discuss the benefits, indications, and future applications of cadaveric skin allografts.

Main Methods:

• Retrospective analysis of 27 patients with 34 lower extremity ulcers treated with cadaveric skin allografts.
• Glycerin-preserved, frozen, cadaveric split-thickness skin allografts were applied to excised wounds.
• Data collected included wound volume, debridement depth, granulation tissue appearance, allograft lifespan, pain levels, and healing time.

Main Results:

• The average allograft lifespan was 29.1 days, with granulation tissue appearing by 13.4 days.
• Pain was reduced in 53% of patients; no infections occurred during allograft application.
• 65% of patients healed by secondary intention, with an average healing time of 113.9 days.

Conclusions:

• Cadaveric skin allografts are beneficial for wound management, particularly for exposed bone or tendon.
• Allografts help prevent desiccation, control infection, and significantly reduce patient discomfort.
• This adjunct therapy shows promise in improving healing outcomes for challenging wounds.